PacWest Financial Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$21.1M Sell
33,699
-364
-1% -$22.2K 1.25% 31
2016
Q3
$2.15M Buy
34,063
+200
+0.6% +$12.9K 1.32% 24
2016
Q2
$2.1M Buy
33,863
+1,020
+3% +$62.2K 1.31% 27
2016
Q1
$1.88M Sell
32,843
-553
-2% -$30.8K 1.21% 34
2015
Q4
$1.98M Buy
33,396
+3,915
+13% +$225K 1.32% 28
2015
Q3
$1.6M Buy
29,481
+3,525
+14% +$229K 1.19% 34
2015
Q2
$1.74M Buy
25,956
+530
+2% +$34.6K 1.23% 36
2015
Q1
$1.49M Buy
25,426
+3,865
+18% +$233K 1.05% 46
2014
Q4
$1.41M Buy
21,561
+125
+0.6% +$7.88K 1% 53
2014
Q3
$1.24M Sell
21,436
-1,225
-5% -$68K 0.92% 59
2014
Q2
$1.28M Buy
22,661
+1,231
+6% +$64.6K 0.95% 53
2014
Q1
$1.1M Buy
21,430
+1,465
+7% +$74K 0.85% 58
2013
Q4
$1.05K Sell
19,965
-225
-1% -$11.1K 0.32% 53
2013
Q3
$903K Buy
20,190
+700
+4% +$31K 0.78% 55
2013
Q2
$806K Buy
+19,490
New +$852K 0.77% 54

Other funds holding ABBV

PacWest Financial Management's ABBV Position: Q4 2016 in Review

PacWest Financial Management reduced its AbbVie (ABBV) stake by 1.1% in Q4 2016, selling an estimated $22.2K and leaving 33,699 shares worth $21.1M. The position accounts for 1.25% of the portfolio, ranked #31.

PacWest Financial Management first reported a position in ABBV in Q2 2013 and has held it in 15 quarters since. 1,692 funds tracked by Wall St. Rank hold ABBV as of Q4 2016.

  • PacWest Financial Management held 33,699 shares of AbbVie worth $21.1M as of Q4 2016.
  • PacWest Financial Management sold 364 AbbVie shares in Q4 2016, an estimated $22.2K.
  • AbbVie made up 1.25% of PacWest Financial Management's portfolio in Q4 2016, its #31 holding.
  • PacWest Financial Management first reported a position in AbbVie in Q2 2013 and has held it in 15 quarters since.
  • 1,692 funds tracked by Wall St. Rank held AbbVie as of Q4 2016.

Based on PacWest Financial Management's 13F filing for Q4 2016, filed 10 Jan 2017.